What are Trump's plans for public health?
From abortion access to vaccine mandates

As the dust settles on Donald Trump's electoral victory, many experts are concerned about how a second Trump term will affect existing policy, and public health could encompass some of the most pressing issues. Trump has been vocal about his mistrust of health agencies. At a rally in Wisconsin, he said his administration would "take on the corruption at the FDA, the CDC, World Health Organization and other institutions of public health," arguing they are dominated by "corporate power" and "China." With controversial Cabinet picks like Robert F. Kennedy, Jr. as the head of the Department of Health and Human Services (HHS), and Dr. Mehmet Oz as head of the Centers for Medicare and Medicaid Services (CMS), a lot can change for the country's public health systems.
What did the commentators say?
The second Trump presidency is "poised to have big impacts on consumer health care," said CNBC. Trump will likely face "few legislative roadblocks" as Republicans now have majorities in all branches of government. With this, Trump will "have the power to influence America's healthcare landscape, including insurance coverage, drug price negotiations, government health and safety regulations and reproductive healthcare access," said Insider.
Health-related agencies are most likely to see a loss in capabilities, namely the Centers for Disease Control and Prevention (CDC) which came under fire following Covid-19. Under Trump, the agency would "most likely lose the authority to enact the few actions it is empowered to use in public emergencies," said The New York Times. This includes "pausing housing evictions, limiting the movements of cruise ships and requiring masks on public transportation." However, a "complete restructuring of the CDC may not be realistic," because it would require congressional support including from moderate Republicans.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
With slashed funding to medical agencies, the "world's largest public funder of biomedical research seems poised for a major overhaul in the next few years," said Scientific American. The National Institute of Health (NIH) has been a "frequent target of Trump and his Republican and other allies." While how restructuring would happen is unclear, "proposals have included everything from shrinking the number of institutes by half to replacing a subset of the agency's staff members." Stifling medical research can have long-term consequences for disease prevention.
Trump's second term could change insurance coverage and abortion access. The president-elect has had a "mixed record" on these issues, said Insider. Despite this, the Trump administration and Project 2025, a conservative policy blueprint, have plans to "try to roll back the Medicaid expansion under the Affordable Care Act, which broadened the pool of people who qualify for coverage." This could be done by capping funding or adding work requirements for Medicaid recipients. As for abortion access, many fear Trump "will seek to impose a federal ban on abortion," but that would require congressional approval, said Time. Even if a measure like this does not pass, Trump may pursue "efforts to restrict access to abortion pills, especially when they are administered through telehealth or delivered by mail," said NBC News.
What next?
Trump's nomination of Dr. Oz to head the CMS has set off alarm bells. The TV doctor has drawn criticism for "espousing scientifically dubious theories and promoting treatments with no documented efficacy," said Axios. Also, he has "no experience running a large government bureaucracy like CMS." Oz has also publicly backed privatized Medicare, which would require a 20% payroll tax, and that has many "concerned that low- and middle-income Americans would be responsible for funding the private insurers," said Newsweek. Complete privatization could also limit access to doctors and hospitals that don't accept insurance.
RFK Jr. has been tapped to head the HHS, which oversees the CMS and other health agencies. He is a longtime vaccine skeptic. Removing all vaccine mandates "would put American children at risk of diseases like measles and polio, which have largely been held at bay by the requirements," said The New York Times. His other ideas are also "wild," said Olga Khazan for The Atlantic. "If his worst ideas come to pass, experts tell me, heart attacks might increase, dental infections might spike, and children might needlessly die of completely preventable diseases."
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Devika Rao has worked as a staff writer at The Week since 2022, covering science, the environment, climate and business. She previously worked as a policy associate for a nonprofit organization advocating for environmental action from a business perspective.
-
EastEnders at 40: are soaps still relevant?
Talking Point Albert Square's residents are celebrating, but falling viewer figures have fans worried the soap bubble has burst
By Elizabeth Carr-Ellis, The Week UK Published
-
What will the thaw in Russia-US relations cost Europe?
Today's Big Question US determination to strike a deal with Russia over Ukraine means Europe faces 'betrayal by a long-term ally'
By Richard Windsor, The Week UK Published
-
Why Spain's economy is booming
The Explainer Immigration, tourism and cheap energy driving best growth figures in Europe
By The Week UK Published
-
Oysters could help combat antibiotic resistance
Under the radar The mollusk shows infection-fighting abilities
By Devika Rao, The Week US Published
-
How Trump's executive orders are threatening scientific research
In the spotlight Agencies are purging important health information
By Devika Rao, The Week US Published
-
New form of H5N1 bird flu found in US dairy cows
Speed Read This new form of bird flu is different from the version that spread through herds in the last year
By Peter Weber, The Week US Published
-
FDA approves painkiller said to thwart addiction
Speed Read Suzetrigine, being sold as Journavx, is the first new pharmaceutical pain treatment approved by the FDA in 20 years
By Rafi Schwartz, The Week US Published
-
America is leaving WHO. What does that mean for public health?
Today's Big Question Trump orders the withdrawal
By Joel Mathis, The Week US Published
-
Why is the FDA slow to ban food additives?
Today's big question A legal loophole lets things slide
By Devika Rao, The Week US Published
-
Is this the end of cigarettes?
Today's Big Question An FDA rule targets nicotine addiction
By Joel Mathis, The Week US Published
-
How close are we to a norovirus vaccine?
Today's Big Question A new Moderna trial raises hopes of vanquishing a stomach bug that sickens millions a year
By David Faris Published